The AI juggernaut is all-in on the healthcare industry, launching three new products in the last six months. But it needs to ...
Tuberculosis, caused by the bacterium Mycobacterium tuberculosis (Mtb), is the world's deadliest single-agent infection, ...
Hosted on MSN
Eli Lilly invests in AI-designed drugs in new deal with Insilico Medicine worth up to €2.39bn
Eli Lilly and Insilico Medicine have struck a new deal on AI-driven drug discovery, the companies announced on Sunday. Under the agreement, worth up to $2.75 ‌billion (€2.39 billion), the American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results